Brain Navi Biotechnology
Hsinchu · Founded 2015
About Brain Navi Biotechnology
Brian Navi Biotechnology Co., Ltd. established in Taiwan and headquartered in Hsinchu Biomedical Science Park, founded in 2015. We cooperate with the well-known Silicon Valley prototype development company Triple Ring Technologies to develop prototypes. We are dedicated to developing innovative navigation and robotic techniques for surgeons to improve the accuracy of streamline surgical procedures and reduce learning curves. With the outstanding doctors, researchers, and developers in Taiwan to combine technical and clinical application experience, developing products driven by demand. Today, Brain tumor, Parkinson's disease, epilepsy and Neural diseases impacts the patients' life. These diseases often easily lead to patient body involuntarily trembling, headache, vomiting, visual disturbances, confusion or physical disability movement and other symptoms. Thus, it will lead to significantly lower the quality of life. Therefore, during the neurosurgery, it is necessary to perform the operation carefully to avoid damage to other brain tissues or vessels. Brain Navi location system can provide the precise information and real-time image to reduce the risk of surgical complications. By using NaoTrac, the neurosurgical navigation robot, doctors can discuss the possible pros and cons to the patient with AI, identify the position and anatomy with computer vision and deliver the procedures delicately with robotic arms. Now, Brain Navi developed Nasal Swab Robot (Brain Navi Nasal Swab Robot) to fight the COVID-19 with the world.
Company Facts
- Founded: 2015
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Funding stage: Seed
- Last round: Non-Equity Assistance (Sep 2020)
- Website: brainnavi.com
- Phone: +88636579438
Social Profiles
Canonical: https://fsome.com/organization/brain-navi-biotechnology-8250748 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.